Study reveals no link between high-density lipoprotein cholesterol and movement disorders

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient’s risk for developing movement disorders while taking an antipsychotic, according to a study published in the April-June issue of Innovations in Clinical Neuroscience.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup